Tag: Xanomeline/trospium chloride

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Xanomeline/trospium chloride

Monument Therapeutics: Precision Neuroscience Company Raises £1 Million - Pulse 2.0

Added to Collection on: 2024-10-20 03:06:20

Tags for this article:

Chlorides
Thiadiazoles
Xanomeline/trospium chloride
Monument Therapeutics

Click the tags to see associated articles and topics

View Article Details
What's Behind the Insider Buying on This High-Yield Stock? - The Globe and Mail

Added to Collection on: 2024-11-11 23:01:44

Tags for this article:

Bristol-Myers Squibb
AbbVie
Apixaban
Xanomeline/trospium chloride
Celgene
Bristol-Myers Squibb Company

Click the tags to see associated articles and topics

View Article Details
2024 Highlights the Rollercoaster That Is Neuro - BioSpace

Added to Collection on: 2024-12-23 05:06:03

Tags for this article:

Orphan drugs
Spinal muscular atrophy
Combination drugs
Azetidines
Emraclidine
Pyridines
Biogen
Xanomeline/trospium chloride
AbbVie
Bristol-Myers Squibb
Aducanumab
Alzheimer's disease
SAGE Therapeutics

Click the tags to see associated articles and topics

View Article Details
Neurodegeneration deals maintain neuroscience momentum - Nature

Added to Collection on: 2025-09-01 16:45:45

Tags for this article:

Alzheimer's disease
TREM2
Xanomeline/trospium chloride
Bristol-Myers Squibb
Neurodegenerative disease

Click the tags to see associated articles and topics

View Article Details
MapLight uses workaround to tee up IPO during government shutdown | BioPharma Dive

Added to Collection on: 2025-10-07 16:01:38

Tags for this article:

Corporate finance
Financial markets
MapLight
Bristol-Myers Squibb
Initial public offering
Xanomeline/trospium chloride
Public offering
Schizophrenia

Click the tags to see associated articles and topics

View Article Details
Can BMYs Neuroscience Portfolio Help to Diversify Its Business? - Yahoo Finance

Added to Collection on: 2025-10-08 16:47:32

Tags for this article:

Alzheimer's disease
Donanemab
Bristol-Myers Squibb
Xanomeline/trospium chloride
Eli Lilly and Company

Click the tags to see associated articles and topics

View Article Details
Can BMYs Neuroscience Portfolio Help to Diversify Its Business? - Nasdaq

Added to Collection on: 2025-10-08 16:15:08

Tags for this article:

Alzheimer's disease
Donanemab
Research and development in the United States
Bristol-Myers Squibb
Xanomeline/trospium chloride
Eli Lilly and Company
Pharmaceutical industry
Securities research
LLY

Click the tags to see associated articles and topics

View Article Details
Book a Demo